HU200926B - Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules - Google Patents
Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules Download PDFInfo
- Publication number
- HU200926B HU200926B HU885621A HU562188A HU200926B HU 200926 B HU200926 B HU 200926B HU 885621 A HU885621 A HU 885621A HU 562188 A HU562188 A HU 562188A HU 200926 B HU200926 B HU 200926B
- Authority
- HU
- Hungary
- Prior art keywords
- weight
- parts
- piroxicam
- tablets
- capsules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU885621A HU200926B (en) | 1988-10-28 | 1988-10-28 | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
| JP1270514A JPH02172918A (ja) | 1988-10-28 | 1989-10-19 | Ｎ―（２―ピリジル）―２―メチル―４―ヒドロキシ―２ｈ―１，２―ベンゾチアジン―３―カルボオキサミド―１，１―ジオキシドを含む薬剤及びその製造方法 |
| CA002001673A CA2001673C (en) | 1988-10-28 | 1989-10-27 | Pharmaceutical composition containing piroxicam |
| FR8914117A FR2638357B1 (fr) | 1988-10-28 | 1989-10-27 | Composition pharmaceutique comprenant du piroxicam et son procede de preparation |
| GB8924286A GB2224207B (en) | 1988-10-28 | 1989-10-27 | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
| IT22164A IT1239542B (it) | 1988-10-28 | 1989-10-27 | Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione |
| AT0247489A AT399277B (de) | 1988-10-28 | 1989-10-27 | Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung |
| IL9213889A IL92138A (en) | 1988-10-28 | 1989-10-27 | Pharmaceutical preparations containing pyroxacam and their preparation |
| DE3936112A DE3936112C2 (de) | 1988-10-28 | 1989-10-30 | Arzneimittelpräparate, die Piroxicam enthalten und Verfahren zu deren Herstellung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU885621A HU200926B (en) | 1988-10-28 | 1988-10-28 | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT51143A HUT51143A (en) | 1990-04-28 |
| HU200926B true HU200926B (en) | 1990-09-28 |
Family
ID=10970484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU885621A HU200926B (en) | 1988-10-28 | 1988-10-28 | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPH02172918A (it) |
| AT (1) | AT399277B (it) |
| CA (1) | CA2001673C (it) |
| DE (1) | DE3936112C2 (it) |
| FR (1) | FR2638357B1 (it) |
| GB (1) | GB2224207B (it) |
| HU (1) | HU200926B (it) |
| IL (1) | IL92138A (it) |
| IT (1) | IT1239542B (it) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2642486B2 (ja) * | 1989-08-04 | 1997-08-20 | 田辺製薬株式会社 | 難溶性薬物の超微粒子化法 |
| JP2964195B2 (ja) * | 1992-04-28 | 1999-10-18 | エスエス製薬株式会社 | ピロキシカム錠及びその製造法 |
| DE19603402A1 (de) * | 1995-02-24 | 1996-08-29 | Basf Ag | Weichgelatinekapseln |
| AU733032C (en) * | 1996-06-14 | 2002-01-03 | Kyowa Hakko Kirin Co., Ltd. | Intraorally rapidly disintegrable tablet |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| JP4568426B2 (ja) * | 1998-04-08 | 2010-10-27 | 協和発酵キリン株式会社 | 錠剤の製造方法及び錠剤 |
| JP2000095674A (ja) | 1998-09-22 | 2000-04-04 | Sato Pharmaceutical Co Ltd | 口腔内崩壊時間短縮化錠剤の製造方法及び装置 |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| EP1574215B1 (en) * | 2002-12-16 | 2015-07-15 | Kissei Pharmaceutical Co., Ltd. | Solid drug for oral use |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| EP2417969A1 (en) | 2004-10-21 | 2012-02-15 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| CN101232905B (zh) * | 2005-07-25 | 2013-01-09 | 大塚制药株式会社 | 一种用于测量嘧啶代谢能力的口服制剂 |
| CN102958515A (zh) | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
| EP2887066B1 (en) | 2012-08-20 | 2020-08-05 | Otsuka Pharmaceutical Co., Ltd. | Composition for use in a method for measuring carbohydrate metabolism ability |
| CN105051533B (zh) | 2013-03-15 | 2019-03-26 | 大塚制药株式会社 | 基于脂肪酸燃烧的测定胰岛素抵抗性的方法及用于该方法的组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
| GB1308533A (en) * | 1969-06-02 | 1973-02-21 | Pfizer | Benzothiazine dioxides as anti-thombotic agents |
| JPS55129221A (en) * | 1979-03-29 | 1980-10-06 | Kaken Pharmaceut Co Ltd | Preparation of oral preparation containing hardly soluble medicine |
| US4350689A (en) * | 1980-02-15 | 1982-09-21 | American Cyanamid Company | Combinations of agents which give enhanced anti-inflammatory activity |
| US4434164A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Crystalline benzothiazine dioxide salts |
| RO88420A (ro) * | 1983-04-25 | 1986-01-30 | Pfizer Inc,Us | Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice |
| DE3419128A1 (de) * | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Dihydropyridinpraeparate und verfahren zu ihrer herstellung |
| CH663899A5 (fr) * | 1985-03-20 | 1988-01-29 | Nestle Sa | Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise. |
| ES545221A0 (es) * | 1985-07-02 | 1986-01-01 | Ferrer Int | Procedimiento de obtencion de particulas de 4-hidroxi-2-me- til-n-2-piridil-2h-1,2-benzotiazina-3-carboxamida-1,1-dioxi-do(piroxicam) recubiertas |
-
1988
- 1988-10-28 HU HU885621A patent/HU200926B/hu unknown
-
1989
- 1989-10-19 JP JP1270514A patent/JPH02172918A/ja active Pending
- 1989-10-27 AT AT0247489A patent/AT399277B/de not_active IP Right Cessation
- 1989-10-27 GB GB8924286A patent/GB2224207B/en not_active Expired - Lifetime
- 1989-10-27 CA CA002001673A patent/CA2001673C/en not_active Expired - Fee Related
- 1989-10-27 IL IL9213889A patent/IL92138A/en not_active IP Right Cessation
- 1989-10-27 FR FR8914117A patent/FR2638357B1/fr not_active Expired - Fee Related
- 1989-10-27 IT IT22164A patent/IT1239542B/it active IP Right Grant
- 1989-10-30 DE DE3936112A patent/DE3936112C2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2638357A1 (fr) | 1990-05-04 |
| GB8924286D0 (en) | 1989-12-13 |
| HUT51143A (en) | 1990-04-28 |
| ATA247489A (de) | 1994-09-15 |
| CA2001673A1 (en) | 1990-04-28 |
| FR2638357B1 (fr) | 1993-10-22 |
| IT1239542B (it) | 1993-11-05 |
| CA2001673C (en) | 1996-08-27 |
| IT8922164A1 (it) | 1991-04-27 |
| GB2224207B (en) | 1992-06-10 |
| IL92138A0 (en) | 1990-07-12 |
| DE3936112A1 (de) | 1990-05-31 |
| JPH02172918A (ja) | 1990-07-04 |
| IL92138A (en) | 1994-08-26 |
| DE3936112C2 (de) | 1999-02-18 |
| AT399277B (de) | 1995-04-25 |
| GB2224207A (en) | 1990-05-02 |
| IT8922164A0 (it) | 1989-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU200926B (en) | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules | |
| US6596311B1 (en) | Fast disintegrating tablets | |
| CA2563440C (en) | Orally disintegrating tablets and methods of manufacture | |
| DE60121570T2 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
| CN100379407C (zh) | 生产咀嚼分散片的方法 | |
| PL206595B1 (pl) | Preparat farmaceutyczny w postaci mikrosfer, sposób wytwarzania tego preparatu oraz farmaceutyczna postać dawkowania zawierająca ten preparat | |
| US9278063B2 (en) | Press-coated orally-disintegrating tablets | |
| JPWO2009084678A1 (ja) | 口腔内崩壊錠およびその製造方法 | |
| DE102004008804A1 (de) | Mehrschichttablette | |
| KR20080096851A (ko) | 에제티미베 조성물 | |
| WO2010035282A1 (en) | Pharmaceutical compositions comprising deferasirox | |
| JPH02164824A (ja) | 分散性製剤 | |
| EP3003277B1 (en) | Process for the preparation of a pharmaceutical composition comprising rivaroxaban | |
| KR20110052731A (ko) | 의약 고형 제제 | |
| JP2013533881A (ja) | バノキセリンを含有する医薬組成物 | |
| US6365196B1 (en) | Controlled release solid dosage forms of lithium carbonate | |
| JP2011246428A (ja) | 口腔内崩壊型医薬品及びその製造方法 | |
| JP2005112861A (ja) | 口腔内速崩壊錠 | |
| EP2387993B1 (en) | Orally disintegrating tablets of zolmitriptan and process for preparing the same | |
| CZ303694B6 (cs) | Prípravek nesteroidního protizánetlivého léciva obsahující granulární a extragranulární kompozici a zpusob jeho prípravy | |
| US20180344648A1 (en) | Clobazam tablet formulation and process for its preparation | |
| EP3511001B1 (en) | Pirfenidone-containing tablet and capsule formulation | |
| JP5900702B2 (ja) | 経口投与用医薬組成物 | |
| JP2017075138A (ja) | ジエノゲスト含有錠剤 | |
| WO2015067313A1 (en) | Orodispersible pharmaceutical compositions comprising aripiprazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC9A | Change of name, address |
Owner name: EGIS GYOGYSZERGYAR NYRT., HU Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR, HU |